Logo (Actavis) 453 (Lamotrigine Extended-Release 200 mg)
Pill with imprint Logo (Actavis) 453 is White, Round and has been identified as Lamotrigine extended-release 200 mg. It is supplied by Actavis Pharma, Inc..
Lamotrigine is used in the treatment of bipolar disorder; seizure prevention; schizoaffective disorder; borderline personality disorder; epilepsy (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo (Actavis) 453
Lamotrigine extended-release
- Imprint:
- Logo (Actavis) 453
- Strength:
- 200 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Triazine anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00228-1453
More about lamotrigine
- Lamotrigine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 893 Reviews
- Drug class: triazine anticonvulsants
Consumer resources
- Lamotrigine
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine (Advanced Reading)
Other brands: Lamictal, Lamictal XR, Lamictal CD, Lamictal ODT
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
